Table 2 Perioperative data
From: Surgical ablation for atrial fibrillation: impact of Diabetes Mellitus type 2
| Â | Group I (non-DM) | Group II (DM) | p Value |
|---|---|---|---|
Included in the study (n) | 484 | 122 | Â |
1-year follow-up (n) | 472 | 116 | |
3-year follow-up (n) | 404 | 92 | |
5-year follow-up (n) | 356 | 79 | |
Ablation type | |||
 Right + Left Atrial ablation (n,%) | 53 (11%) | 23 (18.8%) | 0.067 |
 Left Atrial ablation (n,%) | 417 (86.2%) | 97 (79.5%) |  |
 Other ablation (n,%) | 14 (2.9%) | 2 (1.6%) |  |
 Isolated MAZE procedure (n,%) | 30 (6.2%) | 8 (6.6%) | 0.836 |
 AV surgery (n,%) | 90 (18.6%) | 36 (29.5%) | 0.012 |
 MV surgery (n,%) | 331(68.4%) | 64 (52.5%) | 0.001 |
 TV surgery (n,%) | 134 (27.7%) | 23 (18.8%) | 0.050 |
 CABG (n,%) | 79 (16.3%) | 48 (39.3%) |  < 0.001 |
 Other (n,%) | 60 (12.3%) | 9 (7.4%) | 0.026 |
 Bypass time (min) | 124 (102–150) | 100 (80–121) | 0.028 |
 Cross-clamp time (min) | 100 (80–121) | 92 (75–114) | 0.003 |
 CVA/ TIA (n,%) | 7 (1.4%) | 7 (5.7%) | 0.011 |
 Low Cardiac Output (n,%) | 6 (1.2%) | 4 (3.3%) | 0.121 |
 Acute kidney injury (AKI) (n,%) | 58 (13.7%) | 22 (18%) | 0.087 |
 IABP (n,%) | 2 (0.4%) | 3 (2.5%) | 0.058 |
 Pacemaker (n,%) | 15 (3.1%) | 4 (3.3%) | 1.000 |
 ICU time (hours) | 39 (19–72.8) | 26 (20–60.8) | 0.053 |
 Ventilation time (hours) | 12 (9–16.3) | 11 (8–15) | 0.064 |
 Hospital length of stay (days) | 11 (8–15) | 9 (7–12) | 0.305 |
 1-year mortality (n,%) | 12 (2.5%) | 6 (4.9%) | 0.226 |
 3-year mortality (n,%) | 24 (5.6%) | 11 (10.5%) | 0.076 |
 5-year mortality (n,%) | 34 (11.1%) | 18 (23.4%) | 0.009 |